Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie R Earnshaw

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Pharmacoeconomics|August 12, 2003
Integer/linear mathematical programming models: a tool for allocating healthcare resourcesStephanie R Earnshaw, Susan L Dennett
Clinical Therapeutics|November 24, 2007
Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in CanadaStephanie R Earnshaw, Yola Moride, Sophie Rochon
Stroke|March 17, 2009
Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysisStephanie R Earnshaw, Dan Jackson, Ray Farkouh, et al.
Pharmacoeconomics|March 23, 2013
Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challengesStephanie R Earnshaw, Andrew P Brogan, Cheryl L McDade
Managed Care Interface|December 2, 2006
The effect of recombinant activated factor VII in the treatment of intracerebral hemorrhage on health plan budgetsStephanie R Earnshaw, Michele R Wilson, Ashish V Joshi
Health Care Management Science|August 19, 2007
A linear programming model for allocating HIV prevention funds with state agencies: a pilot studyStephanie R Earnshaw, Katherine Hicks, Anke Richter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2009
Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challengesStephanie R Earnshaw, Michele Wilson, Josephine Mauskopf, et al.
Stroke|September 30, 2006
Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhageStephanie R Earnshaw, Ashish V Joshi, Michele R Wilson, et al.
Health Policy (Amsterdam, Netherlands)|March 18, 2008
Allocating HIV prevention resources: a tool for state and local decision makingAnke Richter, Katherine A Hicks, Stephanie R Earnshaw, et al.
Archives of Internal Medicine|February 18, 2011
Cost-utility of aspirin and proton pump inhibitors for primary preventionStephanie R Earnshaw, James Scheiman, A Mark Fendrick, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics|August 12, 2003
Integer/linear mathematical programming models: a tool for allocating healthcare resourcesStephanie R Earnshaw, Susan L Dennett
Clinical Therapeutics|November 24, 2007
Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in CanadaStephanie R Earnshaw, Yola Moride, Sophie Rochon
Stroke|March 17, 2009
Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysisStephanie R Earnshaw, Dan Jackson, Ray Farkouh, et al.
Pharmacoeconomics|March 23, 2013
Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challengesStephanie R Earnshaw, Andrew P Brogan, Cheryl L McDade
Managed Care Interface|December 2, 2006
The effect of recombinant activated factor VII in the treatment of intracerebral hemorrhage on health plan budgetsStephanie R Earnshaw, Michele R Wilson, Ashish V Joshi
Health Care Management Science|August 19, 2007
A linear programming model for allocating HIV prevention funds with state agencies: a pilot studyStephanie R Earnshaw, Katherine Hicks, Anke Richter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2009
Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challengesStephanie R Earnshaw, Michele Wilson, Josephine Mauskopf, et al.
Stroke|September 30, 2006
Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhageStephanie R Earnshaw, Ashish V Joshi, Michele R Wilson, et al.
Health Policy (Amsterdam, Netherlands)|March 18, 2008
Allocating HIV prevention resources: a tool for state and local decision makingAnke Richter, Katherine A Hicks, Stephanie R Earnshaw, et al.
Archives of Internal Medicine|February 18, 2011
Cost-utility of aspirin and proton pump inhibitors for primary preventionStephanie R Earnshaw, James Scheiman, A Mark Fendrick, et al.
Pageof 4